Clinical Trials Sponsored by Lundbeck Israel

Total 2231 results

H. Lundbeck A/S

Completed

Electroencephalography Study Investigating the Effects of Vortioxetine in Healthy Male Subjects

Healthy Men

France
Rigshospitalet, Denmark
Lundbeck Foundation

Unknown

Study on Baroreceptor Function in Relation to Orthostatic Blood Pressure Regulation After Hip Surgery

Hypotension, Orthostatic | Total Hip Replacement

Denmark
H. Lundbeck A/S

Completed

An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)

Insomnia
H. Lundbeck A/S

Completed

Study Comparing the Gastro-intestinal Tolerability and Absorption Profile of Vortioxetine After Administration of Modified-release Formulations and Immediate-release Formulation in Healthy Women

Healthy Women

United Kingdom
H. Lundbeck A/S

Completed

Effects of Nalmefene After Single Dose on the Blood Oxygen Level Dependent (BOLD) fMRI Signal in the Ventral Striatum to Reward Responding in the Monetary Incentive Delay Task (MIDT), in Non-treatment Seeking Subjects With Alcohol Dependence Following Alcohol Challenge

Alcohol Dependence

United Kingdom
H. Lundbeck A/S

Completed

Bioequivalence Study in Healthy Men and Women to Compare Two Pharmaceutical Formulations of Flupentixol/Melitracen (Deanxit®)

Healthy Men and Women

United Kingdom
H. Lundbeck A/S

Completed

Effect of Multiple Doses of Itraconazole on the Multiple Dose Pharmacokinetics of Lu AE58054 in Healthy Subjects

Healthy Volunteers

France
H. Lundbeck A/S

Completed

Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With Schizophrenia

Schizophrenia | Cognition

United States
Rigshospitalet, Denmark
Lundbeck Foundation

Completed

The Pulmonary Protection Trial

Chronic Obstructive Lung Disease

Denmark
H. Lundbeck A/S

Completed

Open-label Safety Extension Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults

Major Depressive Disorder
Herlev Hospital
Lundbeck Foundation

Completed

Sleep and Cytokines During Acute Diverticulitis

Acute Diverticulitis

Denmark
Herlev Hospital
Lundbeck Foundation

Completed

Subjective Sleep and Fatigue During and After Acute Diverticulitis

Acute Diverticulitis

Denmark
H. Lundbeck A/S

Completed

Randomised Placebo-controlled Duloxetine-referenced Efficacy and Safety Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder

Major Depressive Disorder
H. Lundbeck A/S

Completed

Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 5 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Elderly Patients

Major Depressive Disorder
H. Lundbeck A/S

Completed

Study of Azilect® (Rasagiline) in Levodopa-treated Parkinson's Disease Patients With Motor Fluctuations in Korea

Parkinson's Disease
H. Lundbeck A/S

Completed

Exploratory Study of the Effects of Vortioxetine (Lu AA21004) on Cognition and Blood Oxygen Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Signals in Subjects Remitted From Depression and in Controls

Depression

United Kingdom
H. Lundbeck A/S

Completed

Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies

Dementia With Lewy Bodies | Parkinson's Disease Dementia

Germany
H. Lundbeck A/S

Completed

Safety and Efficacy of Nalmefene in Patients With Alcohol Dependence (SENSE)

Alcohol Dependence

Poland, Russian Federation, Ukraine, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Slovakia, United Kingdom
H. Lundbeck A/S

Completed

Efficacy of Nalmefene in Patients With Alcohol Dependence (ESENSE1)

Alcohol Dependence

Austria, Finland, Germany, Sweden
H. Lundbeck A/S

Terminated

Efficacy of Bifeprunox in Patients With Schizophrenia

Schizophrenia

India, Indonesia, Korea, Republic of, Malaysia, Philippines, Poland, Ukraine
H. Lundbeck A/S

Terminated

Efficacy and Safety of Lu AA34893 in Patients With Bipolar Depression

Depression in Patients With Bipolar Disorder

Austria, Philippines, Australia, Belgium, Bulgaria, Canada, France, Germany, Korea, Republic of, Lithuania, Malaysia, Poland, Romania, Slovakia, Sweden, Taiwan, Ukraine, United Kingdom
H. Lundbeck A/S

Terminated

Efficacy of Bifeprunox in Patients With Schizophrenia

Schizophrenia

Bulgaria, China, Greece, Romania, Russian Federation, Taiwan, Thailand, Ukraine
H. Lundbeck A/S

Completed

A Study of Gaboxadol in Primary Insomnia

Primary Insomnia
BIOTRONIK Israel

Completed

BIOFLOW-III Israel Satellite Registry

Myocardial Ischemia | Coronary Artery Disease | Diabetes Mellitus Type 1 or 2

Israel
Unilever Israel

Unknown

Promoting Health by Self Experience (PHASE) Randomized Controlled Trial (PHASE)

Personal Experience and Personal Initiation Program | Health Prevention Activities | Impact on Patients

Israel
Bar-Ilan University, Israel
Israel Science Foundation

Recruiting

Parental Insightfulness and the Acquisition of Social Skills in Children With ASD. (ASD)

Autism Spectrum Disorder

Israel
H. Lundbeck A/S
Takeda

Completed

Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)

Depressive Disorder, Major

United States, Bulgaria, Canada, Colombia, Estonia, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Mexico, Poland, Russian Federation, Serbia, South Africa, Spain, Ukraine, United Kingdom
Ohio State University
Lundbeck LLC

Completed

Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease

Huntington's Disease

United States
Hvidovre University Hospital
Lundbeck Foundation

Completed

Analgesic Effect of Gabapentin in Total Knee Arthroplasty (TKA)

Postoperative Pain | Postoperative Sedation

Denmark
Takeda
H. Lundbeck A/S

Completed

Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults.

Generalized Anxiety Disorder

Ukraine, Germany, Romania, Russian Federation, Lithuania, Latvia, Estonia, Poland
Takeda
H. Lundbeck A/S

Completed

Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder

Major Depressive Disorder

United States, France, United Kingdom, Germany, Malaysia, Serbia, South Africa, Ukraine, Taiwan, Korea, Republic of, Russian Federation, Lithuania, Latvia, Croatia, Australia, Netherlands, Poland
Takeda
H. Lundbeck A/S

Completed

Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive Disorder

Major Depressive Disorder

United States, Mexico, Canada
Hvidovre University Hospital
Lundbeck Foundation

Completed

Thigh Swelling, Hip-muscle Strength, and Functional Performance Following Total Hip Arthroplasty (THA)

Osteoarthrosis Patients With Total Hip Arthroplasty

Denmark
Qualissima
H. Lundbeck A/S

Terminated

Evaluation of the Tolerance and Acceptability of Rasagiline in the Treatment of Early-stage Parkinson's Disease (ACTOR)

Early-stage Parkinson's Disease
Hvidovre University Hospital
Lundbeck Foundation

Completed

Effects of Methylprednisolone After Total Hip Arthroplasty

Fatigue | Postoperative Pain | Inflammatory Response | Postoperative Nausea and Vomiting | Sleeping Quality | LOS

Denmark
Hvidovre University Hospital
Lundbeck Foundation

Completed

Local Infiltration Analgesia in Bilateral Knee Arthroplasty - Efficacy of Subcutaneous Wound Infiltration With Local Anesthetic

Pain, Postoperative

Denmark
University of Aarhus
Lundbeck Foundation

Recruiting

The Effects of Pain and Pain Relief on Peripheral Nerve Excitability

Analgesia

Denmark
University of Bordeaux
Lundbeck France

Completed

Use of Selincro and Impact on Usual Practice (USE-PACT)

Alcohol Dependence

France
Boston Children's Hospital
Lundbeck LLC

Completed

Electrical Status Epilepticus in Sleep: Response of Neuropsychological Deficits and Epileptiform Activity to Clobazam Treatment (ESES-Clobazam)

Electrical Status Epilepticus in Sleep

United States
University of Aarhus
Lundbeck Foundation

Completed

Somato-sensory Reflex Arch in Spinal Cord Injury - Effect on Colorectal Transport

Spinal Cord Injuries

Denmark
Takeda
H. Lundbeck A/S

Completed

Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder

Generalized Anxiety Disorder

United States
University of Aarhus
Lundbeck Foundation

Completed

Use of Local Infiltration Analgesia Following Total Hip Arthroplasty

Pain | Pain, Postoperative

Denmark
Hvidovre University Hospital
Lundbeck Foundation

Completed

Why in Hospital - Factors Determining Time to Discharge Readiness After Arthroplasty Surgery

Pain | Fatigue | Nausea | Vomiting | Dizzyness | Organizational Concerns | Ect.

Denmark
H. Lundbeck A/S
Takeda

Completed

Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD)

Depressive Disorder, Major

Korea, Republic of, United States, Hungary, Poland, Spain, Serbia, Estonia, Bulgaria, Mexico, Russian Federation, Ukraine, Canada, Colombia, France, Germany, Israel, Italy, Latvia, South Africa
H. Lundbeck A/S
Takeda

Completed

Study of the Efficacy and Safety of Initial Administration of 17 mg Vortioxetine Intravenously With 10 mg/Day Vortioxetine Orally in Patients With Major Depressive Disorder

Depressive Disorder, Major

Finland, Estonia
University of Aarhus
Lundbeck Foundation

Completed

Somato-sensory Reflex Arch in Spinal Cord Injury - Effect on Clinical Outcome

Spinal Cord Injury

Denmark
Takeda
H. Lundbeck A/S

Completed

Study of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder

Generalized Anxiety Disorder

United States
Takeda
H. Lundbeck A/S

Completed

Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Takeda
H. Lundbeck A/S

Completed

Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder

Major Depressive Disorder

France, Ukraine, Germany, Malaysia, South Africa, Korea, Republic of, Russian Federation, Czech Republic, Lithuania, United Kingdom, Latvia, Australia, Netherlands, Poland, Taiwan
Takeda
H. Lundbeck A/S

Completed

An Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder

Generalized Anxiety Disorder

United States

Clinical Trials Sponsored by Lundbeck Israel

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations